RankingsPricing
  1. US-listed companies
  2. GILEAD SCIENCES, INC.
  3. Financials
  4. Revenue growth (%)

GILEAD SCIENCES, INC.GILD

Market cap
$155.4B
P/E ratio
SummaryFinancials
Period EndRevenue growth (%) YoY (%)
Dec 31, 20246-1106.67%
Dec 31, 2023-0.6+566.67%
Dec 31, 2022-0.1-100.85%
Dec 31, 202110.6+6.21%
Dec 31, 202010+583.56%
Dec 31, 20191.5-109.58%
Dec 31, 2018-15.2+8.16%
Dec 31, 2017-14.1+104.50%
Dec 31, 2016-6.9-122.13%
Dec 31, 201531.1-74.53%
Dec 31, 2014122.2+690.94%
Dec 31, 201315.5-1.65%
Dec 31, 201215.7+186.68%
Dec 31, 20115.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)